19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
Seyfarth Synopsis: Waterloo, Iowa has enacted the state’s first “Ban the Box” Ordinance. UPDATE:...
Read More >
Federal law nowadays certainly favors enforcement of agreements to arbitrate. But generally applicab...
Read More >
As previously reported by the Fast Laner, the EEOC announced that it would collect EEO-1 Component 2...
Read More >
In the continued fallout from the “me too” movement, Connecticut Governor Ned Lamont has signed ne...
Read More >
The New York City Council may soon make co-working spaces potentially liable for sexual harassment b...
Read More >
The City of Philadelphia on June 11, 2020 removed all restrictions on properly conducted constructio...
Read More >